Study Startup Specialist
Systimmune
About this role
SystImmune is a clinical-stage biopharmaceutical company focused on developing innovative cancer treatments using cutting-edge biologics. The company is looking for a Study Specialist to coordinate and execute study start-up activities for clinical trials, ensuring timely site activation and regulatory compliance. This role offers an opportunity to contribute to cancer therapeutics development in a dynamic environment.
Skills
About Systimmune
systimmune.comSystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
About Systimmune
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Systimmune.
Salary
$70k – $95k
per year